12. Gahan, L.J., Gould, F., and Heckel, D.G. Cre/+ mice with an adeno-associated virus (AAV) vector carrying a Flip excision (FLEx)-switched Designer Receptor Exclusively Activated by Designer Drugs (DREADD) receptor, hM3Dq. This receptor has been engineered to activate the G q signaling G-protein following binding of a synthetic ligand, clozapine N-oxide (CNO). The FLEx domain in the virus ensures that the receptor will only be expressed in the presence of the Cre recombinase, which in turn is driven only in melanopsinexpressing cells (Figure 1 ). Thus, CNO in theory should mimic the effect of light on mRGCs, as melanopsin is believed to couple primarily to G q [4] . The group demonstrated that their AAV vector infected about a third of the native mRGCs, and that hM3Dq was expressed only in these cells. The researchers demonstrated that administration of CNO mimicked known light effects on mRGCs, including stimulating pupillary constriction and phase shifting free-running circadian rhythms. Neither effect was seen in the absence of either CNO or AAV infection.
The group then asked the question, what brain regions are activated in response to mRGC cell firing? Induction of the immediate early gene c-fos was used as a surrogate marker for neuronal activation. Not surprisingly, when CNO was given in the early subjective night, the SCN showed marked c-fos induction. Other 
Current Biology
Dispatches hypothalamic nuclei that demonstrated activation included the paraventricular hypothalamus (PVN), dorsomedial hypothalamus and dorsal hypothalamic area (DMH/DHA), and the lateral hypothalamic area (LHA). The study was remarkable, however, for those regions that did not show c-fos inductionnotably, the ventrolateral preoptic area (VLPO). This distinction is important, as the PVN, DMH/DHA, and LHA are all areas thought to be associated with alertness and corticosteroid release [5] , while the VLPO is thought to play an important role in the genesis of sleep [6] . In other areas of the brain, c-fos was found to be induced in nuclei of the amygdala and paraventricular and intralaminar thalamic nuclei, areas also associated with alertness and vigilance.
Is this c-fos activation associated with observable behavioral changes? The researchers next tested animals with chemogenetic activation of mRGCs in a series of standard behavioral assays conducted under dim red light. Results with both open field test and elevated plus-maze demonstrated significantly increased alertness/anxiety behavior when melanopsin mRGCs were chemically activated. Importantly, the authors did not observe increased depressive behavior in forced swim testing (consistent with lack of c-fos activation in the habenula [7] ).
One could argue that these experiments could have been performed in mice having only melanopsin mRGCs (i.e., in a mutant with complete outer retinal degeneration), using natural light as stimulus. However, retinal degeneration induces extensive intraretinal remodeling [8, 9] . It is possible that this remodeling could extend to changes in retinal ganglion cell function or targeting as well. A second potential way to isolate melanopsin's effect in an anatomically intact animal would be to stimulate this pigment specifically using monochromatic light near its absorption maximum but insufficiently intense to activate cone photopigments. Such an approach was recently published by Pilorz et al. [10] , who compared the effects of 470 nm light (near peak absorption wavelength for melanopsin) to 530 nm light (near peak for the M-cone). Similar to the Milosavljevic et al. work, these authors found that in wild-type mice, 470 nm had a net alerting effect, while 530 nm light was profoundly soporific. However, in mice lacking melanopsin, 470 nm light induced sleep. This work suggests that the sleepinducing effects of light on mice (which are nocturnal) are not mediated through melanopsin but through other pathways. (Whether these are the classical visual pathways or the newly described neuropsin-expressing RGCs [11] remains to be determined.) Interestingly, Pilorz et al. [10] found that in melanopsin-less animals, green light paradoxically delayed sleep induction (an effect which could perhaps help explain the diurnal phenotype occasionally seen in melanopsin knockout mice [12] ).
Light does not appear to influence sleep or wakefulness in animals in which mRGCs have been genetically ablated [13] . This suggests that all photic information reaching sleep centers in the brain require mRGCs. However, the current studies suggest that light signaling by mRGCs is not sufficient for mediating lightinduced sleep in mice. How can mRGCs be necessary but not sufficient for transducing photic information mediating sleep? One possibility is that chemogenetic stimulation is equivalently activating different subsets of mRGCs which normally would not fire together under natural lighting conditions; for instance, in vivo, some subsets of mRGCs such as M2 cells are less light-sensitive than M1 cells and project to different brain regions [14] , but all subsets would be equivalently activated chemogenetically. The resulting pattern of stimulation may not result in sleep. Alternatively, brain regions may recognize mRGC signal patterns arising from rods and cones as distinct from that arising from melanopsin, thus permitting the outer retinal signals to influence sleep while melanopsin-derived signals are ignored. This paradox is worthy of further study.
Taken together, these recent studies also suggest unexpected complexity of non-visual light-sensing. In particular, the finding that longer wavelength light is sleep-inducing in mice while shorter wavelength light is alertness-inducing suggests that the unique action spectra of each opsin does more than encode visual color; it also provides a colordependency to non-visual phenomena such as circadian timing, sleep and wakefulness [15] . It is possible -indeed likely -that the spectrum of artificial lighting in which we now spend much of our lives may have unintended and untoward effects on alertness, sleep, and wakefulness, as has recently been suggested in comparing sleep and activity rhythms in electrified versus non-electrified communities [16] .
Perhaps most interesting in this work is the indication of the properties a pharmacologic melanopsin agonist would have. While melanopsin antagonists have been described [17] 
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Cre/+ mice are injected with AAV expressing a FLEx-activated DREADD receptor, hM3Dq (green). Following injection, three types of cells will be found in the retina (middle): mRGCs expressing Cre (red), AAV-infected cells (green), and co-expressing cells which will express DREADD (yellow). Following administration of the synthetic ligand CNO, only infected Opn4-positive cells will be activated. Areas of the brain specifically activated by mRGCs, as well as effects on behavior, may then be analyzed. be able to shift the circadian clock. This pathway could also be manipulated to ameliorate seasonal affective disorder [18] . A drug that made one happier and more alert by specifically activating a few thousand retinal ganglion cells would be a remarkable advance indeed.
